-Identify the original 2 patents on beta-3-adrenoc

-Identify the original 2 patents on beta-3-adrenoceptors that were assigned to Glaxo

The primary theme of the paper is -Identify the original 2 patents on beta-3-adrenoceptors that were assigned to Glaxo in which you are required to emphasize its aspects in detail. The cost of the paper starts from $99 and it has been purchased and rated 4.9 points on the scale of 5 points by the students. To gain deeper insights into the paper and achieve fresh information, kindly contact our support.

Patents search

INSTRUCTIONS:
Jonathan Spadt`s presentation on intellectual property was focused on the drug Solabegron (http://en.wikipedia.org/wiki/Solabegron ), which is a beta-3-adrenoceptor compound. In order to develop some additional background on searching for and understanding patents, please prepare a short write-up (bullet item lists are fine) in which you: 1--Identify the original 2 patents on beta-3-adrenoceptors that were assigned to Glaxo (the company name was Glaxo Wellcome at that time). When were these filed and when were they actually approved? 2--The Claims actually define what is covered by the patent. How many claims are there in the 2001 Glaxo patent? Read through the Claims and provide a brief summary. 3--What is "novel" in the 2001 Glaxo patent according to the inventors? 4--Identify all subsequent patents that reference the 2001 Glaxo patent. What companies filed these patents? There are a number of different web resources for searching patents. The ones I recommend are: www.uspto.gov (this is the official US government site) and www.google.com/patents. There is also information available on patent searching through the Penn State libraries at http://www.libraries.psu.edu/psul/pams/patent.html.
CONTENT:
Running head: Patents searchPatents on beta-3-adrenoceptorsName:Subject:College:Instructor:DateIntroductionBeta-3-adrenoceptors also referred to as Atypical beta-adrenoceptors is a chemical compound initially believed to treat conditions such as type 2 diabetes, preterm labor, obesity, , heart failure depressions and anxiety. This compound has undergone a number of filed patent petitions by different companies and incorporations in the United States among other nations. This brief description therefore identifies some of the initial patents on beta-3-adrenoceptor to be filed and accepted by the United States Patent and Trademark Office.The first Patent to be filed and issued upon acceptance by the US government with respect to this chemical was presented by Glaxo Inc. back in the year 1998. The first patent with patent number: 6048872 were filed on the 5th of June, 1998. This patent was fully approved on the 11th of April 2000. This patent was granted based on the arguments that this chemical compound had the capacity to treat a...
100% Plagiarism Free & Custom Written, Tailored to your instructions